World Health Organization Disability Assessment Schedule II (WHODAS-II) for Patients With Symptomatic Lumbar Spinal Stenosis

Kovacs Foundation200 enrolled

Overview

The main purpose of this study is to determine the measurement characteristics of WHODAS-II (World Health Organization Disability Assessment Schedule II), as well as to analyze its correlation with symptomatic lumbar spinal stenosis (Visual Analog Scale, VAS), disability (Spanish version of the Roland Morris Questionnaire, RMQ), fear avoidance beliefs and attitudes (Spanish version of the FAB Questionnaire, FABQ), and quality of life (SF-12). Measurements will be taken at baseline and 6 days later (day 7).

Study Type

OBSERVATIONAL

Enrollment

200

Conditions

Lumbar Spinal Stenosis

Interventions

WHODAS II (World Health Organization Disability Assessment Schedule II)OTHER

To determine the measurement characteristics of WHODAS II (World Health Organization Disability Assessment Schedule).

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients seen for symptomatic lumbar spinal stenosis * With signs of neurogenous claudication * MRI or CAT scan concordant with observed signs * Able to read and write * Have signed the informed consent form Exclusion Criteria: * Central nervous system pathology (with or without treatment) * Diagnosis of rheumatic inflammatory disease or fibromyalgia * Red flags for underlying systemic disease * Criteria for diagnosis of disc herniation * Symptoms suggesting saddle anesthesia, cauda equina, loss of sphincter tone or paraparesis * Motor deficit that progresses or does not improve in 6 weeks

Locations (1)

Hospital Universitario Marqués de Valdecilla

Santander, Cantabria, Spain

Outcomes

Primary Outcomes

Measurement characteristics of WHODAS-II

Time frame: At baseline and at 7 days

Secondary Outcomes

Correlation between WHODAS-II and VAS, RMQ, FABQ and SF-12 in symptomatic lumbar spinal stenosis

Time frame: At baseline and at 7 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.